Market Research Logo

Netherlands Pharmaceuticals and Healthcare Report Q2 2016


Attention: There is an updated edition available for this report.

Netherlands Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The value of the Dutch pharmaceutical market will see yet another year of contraction in 2016,although we expect a return to growth - albeit marginal - in the following years. A relatively low riskenvironment and a well establish healthcare sector, thanks to high government expenditure, coupled withan aging population will aid in the recovery of the market. However, the country's ever-growing healthcarebills will increase the likelihood of the government implementing further cost-containment measures.

Headline Expenditure Projections

Pharmaceuticals: EUR5.80bn (USD6.38bn) in 2015 to EUR5.80bn (USD6.20bn) in 2016; -0.1% inlocal currency terms and -2.8% in US dollar terms. Forecast in line with last quarter.

Healthcare: EUR74.29bn (USD81.72bn) in 2015 to EUR75.48bn (USD80.77bn) in 2016; +1.6% in localcurrency terms and -1.2% in US dollar terms. Forecast unchanged from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Netherlands 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Netherlands 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Netherlands 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Netherlands 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Netherlands 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Netherlands 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Netherlands 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Netherlands 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Netherlands 2014-2020)
Industry Risk Reward Index
Western Europe Risk/Reward Index
Netherlands Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Netherlands 2010-2015)
Table: Healthcare Personnel (Netherlands 2010-2015)
Table: Healthcare Activity (Netherlands 2010-2015)
Table: Key Points Of The Dutch Health Insurance Act, January 1 2006
Table: Biosimilars Approved In The EU
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Pharmaceutical Production, 1995-2010 (EUR '000s)
Generic Drugmakers
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
DSM
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Pharming Group
Qiagen
Sanofi
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Netherlands 1990-2025)
Table: Key Population Ratios (Netherlands 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Netherlands 1990-2025)
Table: Population By Age Group (Netherlands 1990-2025)
Table: Population By Age Group % (Netherlands 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report